Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts
- 2020年06月01日 16:00:00
- テクノロジー
- JCN Newswire
Impact Biomedical previously announced on 23 April 2020 that the Suite was valued at USD 592 million (SGD 841 million) by Destum Partners. Unlike the previous valuation, the new valuation of the Suite conducted, which was initiated by GRDG Sciences, takes into consideration numerous additional disease applications of the Suite. The scope of the new valuation of the Suite includes: 3F Mosquito and Antiviral Biofragrance;Equivir, an OTC medication with broad antiviral activity;Laetose, an advanced sugar replacement that is reduced calorie and low glycemic;and Linebacker, a broad-spectrum universal therapeutic.
The Company refers to its announcement on 4 May 2020 in relation to Impact Biomedical's entry into a share exchange agreement for a proposed US$50 million share swap. The Company wishes to state that as the terms of the share swap transaction has been finalized prior to the new valuation, the new valuation amount of the suite will not vary the terms and consideration of the share swap transaction.
Impact Biomedical and GRDG Sciences developed this Suite in a long-term research program adhering to the principles and initiatives established by the Panacea program, the Open Air Defense Initiative, Project Bioshield and the Biomedical Advanced Research and Development Authority ("BARDA") of the U.S. Department of Health and Human Services.
3F Biofragrance was designed for the Open Air Defense Initiative, a strategy to protect locations where large numbers of people gather or transit such as airports, containment areas, train stations, convention centers, hospitals, and other appropriate enclosed spaces, and ports of entry. 3F Mosquito Biofragrance and Mosquito Booster are a multi-aspect inhibitors of mosquito receptors that shut down the ability of the insects to detect human prey and they deactivate the feeding impulse. 3F Antiviral Biofragrance has proven to be successful against E. coli, MRSA, Influenza, Rhinovirus, Tuberculosis, and COVID-19. All three Biofragrance technologies are patent pending and were valued for their mosquito repellent, mosquito repellent boosting, and antimicrobial disinfectant applications.
Equivir was created as a solution for Project Bioshield, a U.S. government program to conduct and support research and development activities for countermeasures in biological emergencies. Equivir is a patented OTC medication/vitamin that has broad antiviral efficacy and was valued for its use as a prophylactic and treatment against multiple types of Influenza, Rhinovirus, Cholera, Ebola, and COVID-19.
Linebacker was modeled to shadow the Panacea program created by the US Defense Advanced Research Projects Agency ("DARPA"). Panacea was a research program designed to provide novel, multi-target therapeutics for unmet physiological needs. Linebacker is a patented universal therapeutic medication and was valued for its demonstrated effectiveness against neurological diseases including Parkinson's, 17 types of cancer, and multiple pathogens such as MRSA, E. coli, A. baumannii, K. penumoniae, S. flexneri, Cholera, Influenza, SARS, MERS, Malaria, and COVID-19.
Laetose is a reduced calorie and low glycemic sugar replacement created to address the rising global problem of metabolic disorders and associated conditions such as obesity and diabetes.
GRDG Sciences's Chief Scientific Advisor is Dr. Roscoe M. Moore, Jr., the former United States Assistant Surgeon General and former Epidemic Intelligence Service Officer at Centers for Disease Control and Prevention or CDC. He said, "GRDG's broad set of technology clearly shows a comprehensive approach to provide solutions to global healthcare that is poised to make a real impact and improve the lives of many people around the world."
Also advising GRDG Sciences is Lieutenant Colonel William H. Lyerly Jr., retired Career Senior Executive / Scientific Professional from the U.S. Department of Homeland Security and retired U.S. Army Medical Service Corps Officer. Lieutenant Colonel Lyerly also served as a senior official in the U.S. Department of Health and Human Services, the U.S. Agency for International Development, and the U.S. Executive Office of the President (White House). Lieutenant Colonel Lyerly states, "GRDG has a wide range of novel, unique capabilities which are reflected in this valuation. Each aspect is important on its own and the combination of assets is simply astounding."
Impact Biomedical accomplished this research and development in strategic partnership with GRDG Sciences led by Mr. Chan Heng Fai, Chairman. "I am greatly encouraged with the results and the team's contribution to this cause. We hope this will eventually prove to be beneficial to everyone and we look forward to more exciting discoveries"said Mr. Chan.
Daryl Thompson, Director of Scientific Initiatives and founder of GRDG Sciences said, "This valuation validates the 5-year project to prove the speed in which biomedical countermeasure research can be achieved, a major accomplishment especially in the present atmosphere of the COVID pandemic."GRDG Sciences is working with large global companies and organizations to license and integrate this technology into pipelines and programs for further validation, regulatory approval, and deployment to treat or prevent multiple threats to the health of people worldwide.
Shareholders and potential investors of SeD are advised to read this Press Release and any further announcements made by SeD carefully. Shareholders and potential investors of SeD are advised to refrain from taking any action with respect to their securities in SeD which may be prejudicial to their interests, and to exercise caution when dealing in the securities of SeD. Shareholders and potential investors of SeD should consult their stockbrokers, bank managers, solicitors or other professional advisers if they have any doubt about the actions they should take.
About Singapore eDevelopment Limited
Incorporated on 9 September 2009 and listed on the Singapore Exchange in July 2010, Singapore eDevelopment Limited is involved in (i) property development and investments primarily in the United States and Western Australia;(ii) information technology-related businesses;(iii) development, research, testing, manufacturing, licensing and distribution of biomedical products;and (iv) investment activities. For more information, please visit: www.SeD.com.sg or email contact@sed.com.sg.
About Impact BioMedical, Inc.
Impact BioMedical, Inc. ("Impact BioMedical") is a wholly-owned direct subsidiary of Global BioMedical Pte. Ltd., which in turn is a wholly-owned direct subsidiary of Singapore eDevelopment Limited, a company listed on the Singapore Exchange. Impact BioMedical strives to leverage its scientific know-how and intellectual property rights to provide solutions that have been plaguing the biomedical field for decades. By tapping into the scientific expertise of GRDG Sciences, LLC. and Australian Exchange-listed Holista CollTech Limited, Impact BioMedical pledges to undertake a concerted effort in the R&D, drug discovery and development for the prevention, inhibition, and treatment of neurological, oncological and immuno related diseases.
About GRDG Sciences, LLC.
GRDG Sciences, LLC is an advanced research team formed in Florida by natural products discovery drug research scientist, Daryl Thompson. For more information, please visit: http://www.globalrdg.com.
Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
「ゴミ箱にお魚を捨てたら…!?」ここにあるのは分かっているにゃ!と言わんばかりに大興奮!
【6月2日生まれの著名人】平泉成、三沢あけみ、鷲尾真知子、山口ひろみ、ピース又吉直樹ら
【横浜】スローイン妨害、少し触るだけで笛、質問には警告…激高のキューウェル監督、主審猛批判
【C大阪】レオ・セアラ、13ゴール目も2戦連続ドローでブーイング「しょうがない」
東日本や東北 「寒冷渦」通過 週明けにかけて不安定 沖縄は再び大雨か 週間天気
槇原敬之FM802開局35周年ライブのトリ 全員で「世界に一つだけの花」合唱
Accutar Biotechnology、ASCO 2024にてER +/ HER2-乳がん患者におけるAC699単剤療法の第1相試験データを発表
中西太さんの銅像の建立が決定 27年秋までに故郷の高松市に 西鉄ライオンズの黄金期を支える
【ヤクルト】5連敗で交流戦未勝利 高津監督「らしさがない」「思い切ってやればいい」
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
柏原崇(45)現在を調べてみた結果、相変わらずかっこよすぎた!
大原櫻子、ガーシー暴露後初のSNS投稿に賛否の声「イメージ最悪になった」
「暴露します」松本人志飲み会参加セクシー女優「衝撃作」発売「言えなくてずっと溜めてた」
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
漫才師の今くるよさん死去 膵がんのため
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
浜崎あゆみ、子供の写真公開に疑いの声止まず「よそのお宅の子供?」
大谷翔平被弾投手が悪態ついて退場処分!次打者フリーマンと対戦中に判定巡り塁審と口論
金正恩の妹・金与正関連のネタ投稿がTwitterで大量に出回る
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
柏原崇(45)現在を調べてみた結果、相変わらずかっこよすぎた!
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
元めちゃイケメンバーの三中元克(32)現在は何をしているのか調べてみた!
TikTokを賑わす「フエラムネごめんなサイダー味」がセブンイレブンで再販!じゅるるマスカットも買うなら今!
小倉優子、不自然な“二重ライン”にネット騒然「やっぱり整形?」
ガーシーが綾野剛のLINE公開でネット騒然「ショック」「すごいエンタメ」
岡本夏生(56)、1600日ぶりにブログを更新した現在が衝撃
大原櫻子、ガーシー暴露後初のSNS投稿に賛否の声「イメージ最悪になった」
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
「どこのアイドルさんかと…」本田紗来、リボン着用の最新ショットが話題 姉望結の誕生日を祝福
「ゴミ箱にお魚を捨てたら…!?」ここにあるのは分かっているにゃ!と言わんばかりに大興奮!
【6月2日生まれの著名人】平泉成、三沢あけみ、鷲尾真知子、山口ひろみ、ピース又吉直樹ら
【横浜】スローイン妨害、少し触るだけで笛、質問には警告…激高のキューウェル監督、主審猛批判
槇原敬之FM802開局35周年ライブのトリ 全員で「世界に一つだけの花」合唱
【C大阪】レオ・セアラ、13ゴール目も2戦連続ドローでブーイング「しょうがない」
東日本や東北 「寒冷渦」通過 週明けにかけて不安定 沖縄は再び大雨か 週間天気
Accutar Biotechnology、ASCO 2024にてER +/ HER2-乳がん患者におけるAC699単剤療法の第1相試験データを発表
中西太さんの銅像の建立が決定 27年秋までに故郷の高松市に 西鉄ライオンズの黄金期を支える